| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 11 | 0 | 0 | 11 |
| USP1 protein, partial | 8 | 0 | 0 | 8 |
| AR protein | 15 | 0 | 0 | 15 |
| nuclear receptor subfamily 1, group I, member 3 | 10 | 0 | 0 | 10 |
| EWS/FLI fusion protein | 2 | 0 | 0 | 2 |
| glucocorticoid receptor [Homo sapiens] | 15 | 0 | 0 | 15 |
| retinoic acid nuclear receptor alpha variant 1 | 12 | 0 | 0 | 12 |
| estrogen-related nuclear receptor alpha | 14 | 0 | 0 | 14 |
| farnesoid X nuclear receptor | 8 | 0 | 0 | 8 |
| estrogen nuclear receptor alpha | 17 | 0 | 0 | 17 |
| peroxisome proliferator-activated receptor delta | 8 | 0 | 0 | 8 |
| peroxisome proliferator activated receptor gamma | 9 | 0 | 0 | 9 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 9 | 0 | 0 | 9 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 13 | 0 | 0 | 13 |
| activating transcription factor 6 | 7 | 0 | 0 | 7 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 5 | 0 | 0 | 5 |
| Histone H2A.x | 5 | 0 | 0 | 5 |
| Bloom syndrome protein isoform 1 | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 10 | 0 | 0 | 10 |
| heat shock protein beta-1 | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 12 | 0 | 0 | 12 |
| nuclear receptor ROR-gamma isoform 1 | 8 | 0 | 0 | 8 |
| geminin | 13 | 0 | 0 | 13 |
| peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
| lamin isoform A-delta10 | 8 | 0 | 0 | 8 |
| ATP-binding cassette sub-family C member 3 | 0 | 7 | 0 | 7 |
| Multidrug resistance-associated protein 4 | 0 | 7 | 0 | 7 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Bile salt export pump | 0 | 8 | 0 | 8 |
| Cellular tumor antigen p53 | 11 | 0 | 0 | 11 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Retinoic acid receptor alpha | 0 | 3 | 3 | 9 |
| 60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Retinoic acid receptor beta | 0 | 3 | 3 | 9 |
| Retinoic acid receptor gamma | 0 | 3 | 3 | 9 |
| Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
| Glutamate receptor 2 | 10 | 0 | 0 | 10 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Spike glycoprotein | 6 | 0 | 0 | 6 |
| 10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Thiosulfate sulfurtransferase | 0 | 3 | 0 | 3 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| 10 kDa chaperonin | 0 | 3 | 0 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 7 | 0 | 7 |
| ATP-dependent phosphofructokinase | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 5 | 0 | 0 | 5 |
| thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| GLI family zinc finger 3 | 12 | 0 | 0 | 12 |
| progesterone receptor | 10 | 0 | 0 | 10 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
| pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
| IDH1 | 4 | 0 | 0 | 4 |
| aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
| nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
| galanin receptor type 3 | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-1 | 0 | 10 | 0 | 10 |
| Glycine receptor subunit beta | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-2 | 0 | 10 | 0 | 10 |
| Glycine receptor subunit alpha-3 | 0 | 10 | 0 | 10 |
| ORF73 | 0 | 0 | 1 | 1 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| Chain A, Ferritin light chain | 6 | 0 | 0 | 6 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| PPM1D protein | 1 | 0 | 0 | 1 |
| Microtubule-associated protein tau | 7 | 0 | 0 | 7 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| euchromatic histone-lysine N-methyltransferase 2 | 9 | 0 | 0 | 9 |
| mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
| Interferon beta | 9 | 0 | 0 | 9 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 3 | 1 | 5 |
| Cytochrome P450 3A4 | 0 | 4 | 1 | 6 |
| Androgen receptor | 0 | 1 | 0 | 1 |
| Cytochrome P450 2D6 | 0 | 2 | 1 | 3 |
| Vitamin D3 receptor | 0 | 1 | 2 | 4 |
| Cytochrome P450 2C9 | 0 | 3 | 1 | 5 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 3 | 5 |
| Cytochrome P450 2C19 | 0 | 5 | 1 | 6 |
| Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 4 | 0 | 0 | 4 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
| Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
| Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 3 | 0 | 0 | 3 |
| Luciferase | 5 | 0 | 0 | 5 |
| interleukin 8 | 1 | 0 | 0 | 1 |
| thioredoxin reductase | 6 | 0 | 0 | 6 |
| phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
| GLS protein | 3 | 0 | 0 | 3 |
| TDP1 protein | 15 | 0 | 0 | 15 |
| aldehyde dehydrogenase 1 family, member A1 | 5 | 0 | 0 | 5 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| luciferase | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 3 | 0 | 0 | 3 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| DNA polymerase iota isoform a (long) | 5 | 0 | 0 | 5 |
| DNA polymerase kappa isoform 1 | 3 | 0 | 0 | 3 |
| survival motor neuron protein isoform d | 7 | 0 | 0 | 7 |
| cytochrome P450 3A4 isoform 1 | 6 | 0 | 0 | 6 |
| histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit pi | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 6 | 0 | 0 | 6 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 6 | 0 | 0 | 6 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 6 | 0 | 0 | 6 |
| Tyrosine-protein phosphatase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 6 | 0 | 0 | 6 |
| Alpha-synuclein | 2 | 1 | 0 | 3 |
| Nuclear receptor ROR-gamma | 3 | 1 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 6 | 0 | 0 | 6 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
| GABA theta subunit | 6 | 0 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit epsilon | 6 | 0 | 0 | 6 |
| Chain A, Cruzipain | 5 | 0 | 0 | 5 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| ATAD5 protein, partial | 5 | 0 | 0 | 5 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
| retinoid X nuclear receptor alpha | 7 | 0 | 0 | 7 |
| G | 7 | 0 | 0 | 7 |
| bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 9 | 0 | 0 | 9 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 5 | 0 | 0 | 5 |
| vitamin D3 receptor isoform VDRA | 5 | 0 | 0 | 5 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 4 | 0 | 0 | 4 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| HLA class I histocompatibility antigen, B alpha chain | 7 | 0 | 0 | 7 |
| Androgen receptor | 0 | 9 | 0 | 9 |
| Inositol hexakisphosphate kinase 1 | 7 | 0 | 0 | 7 |
| cytochrome P450 2C9, partial | 7 | 0 | 0 | 7 |
| Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
| ATPase family AAA domain-containing protein 5 | 7 | 0 | 0 | 7 |
| Ataxin-2 | 7 | 0 | 0 | 7 |
| Smad3 | 3 | 0 | 0 | 3 |
| urokinase-type plasminogen activator precursor | 2 | 0 | 0 | 2 |
| plasminogen precursor | 2 | 0 | 0 | 2 |
| urokinase plasminogen activator surface receptor precursor | 2 | 0 | 0 | 2 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| calpain II, partial | 0 | 1 | 0 | 1 |
| PAX8 | 0 | 0 | 0 | 1 |
| glp-1 receptor, partial | 5 | 0 | 0 | 5 |
| SUMO-1 | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| Valosin-containing protein | 0 | 1 | 0 | 1 |
| TSHR protein | 1 | 0 | 0 | 1 |
| Estrogen receptor 1 | 0 | 1 | 0 | 1 |
| PINK1 | 1 | 0 | 0 | 1 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| envelope glycoprotein | 0 | 1 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 6 | 0 | 0 | 6 |
| nonstructural protein 1 | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
| Parkin | 3 | 0 | 0 | 3 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| heat shock 70kDa protein 1A | 0 | 1 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 2 | 0 | 0 | 2 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| galactokinase | 1 | 0 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| neuropeptide Y receptor type 1 | 0 | 0 | 1 | 1 |
| neuropeptide Y receptor type 2 | 0 | 0 | 1 | 1 |
| small ubiquitin-related modifier 2 isoform b precursor | 0 | 1 | 0 | 1 |
| caspase-3 | 3 | 0 | 0 | 3 |
| estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| enteropeptidase precursor | 1 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
| fatty acid synthase | 0 | 1 | 0 | 1 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| heat shock cognate 71 kDa protein isoform 1 | 0 | 1 | 0 | 1 |
| eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
| Vpr | 2 | 0 | 0 | 2 |
| 4-(cytidine 5'-phospho)-2-C-methyl-D-erithritol kinase | 1 | 0 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| heat shock cognate 71 kDa protein isoform 2 | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Tissue-type plasminogen activator | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Plasminogen activator inhibitor 1 | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 2 | 2 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 1 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1a | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Adenosine receptor A3 | 0 | 6 | 0 | 6 |
| Replicase polyprotein 1ab | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 1 | 2 |
| Endoplasmic reticulum chaperone BiP | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 2 | 1 | 3 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 1 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 3 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 3 | 0 | 3 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 6 | 0 | 6 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
| Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| TAR DNA-binding protein 43 | 1 | 0 | 0 | 1 |
| Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 0 | 0 | 2 | 2 |
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
| N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 2 | 0 | 0 | 2 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| BZLF2 | 0 | 1 | 0 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| serine/threonine-protein kinase mTOR isoform 1 | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| Ornithine decarboxylase | 0 | 0 | 0 | 2 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 4 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 4 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 2 | 2 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 1 | 0 | 2 | 0 | 3 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 2 | 2 |
| Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
| GALC protein | 2 | 0 | 0 | 2 |
| cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
| cytochrome P450 2C19 precursor | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| Fumarate hydratase | 1 | 0 | 0 | 1 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| polyprotein | 1 | 0 | 0 | 1 |
| arylsulfatase A | 2 | 0 | 0 | 2 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| chromobox protein homolog 1 | 6 | 0 | 0 | 6 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Integrin beta-3 | 1 | 0 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 1 | 0 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Platelet-activating factor receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 2 | 1 | 3 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Sodium-dependent neutral amino acid transporter B(0)AT2 | 0 | 1 | 0 | 1 |
| Histamine H4 receptor | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 1 |
| Estrogen receptor | 0 | 4 | 0 | 4 |
| Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Progesterone receptor | 0 | 2 | 2 | 4 |
| Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
| Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 3 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 2 | 1 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
| Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |